
While EMRs have improved clinician workflow in recent years, they are not perfect. Paper charts may still have a place in cancer clinical research.
While EMRs have improved clinician workflow in recent years, they are not perfect. Paper charts may still have a place in cancer clinical research.
Oncology nurses often face incivility from their peers, but there are methods they can use to combat the stress of a toxic work environment.
There is currently no way to measure chemotherapy-induced peripheral neuropathy in pediatric patients, but a team of nurse researchers are developing a new tool to meet this need.
As nurses navigate cancer care during the COVID-19 pandemic, it is especially important that they have their voices heard – and their votes counted.
The Food and Drug Administration (FDA) approved pralsetinib (Gavreto) for the treatment of patients with metastatic, RET fusion-positive non-small cell lung cancer (NSCLC), according to Genentech, the co-manufacturer of the drug.
The Centers for Medicare & Medicaid Services may expand telemedicine and home healthcare access. However, ASCO warned them of the dangers of in-home chemotherapy infusions.
We asked our audience about how the COVID-19 pandemic changed nursing school. Here’s what some of them had to say.
The NCI and Cancer Research UK are coming together to improve cancer care around the world.
The coronavirus disease 2019 (COVID-19) pandemic has affected nursing school at both the graduate and undergraduate level. While online classes may be convenient, a lack of in-person and hands-on training is a clear downside for those learning the trade.
The COVID-19 pandemic can affect every stage of the cancer experience: from diagnosis to adverse event management.
Locally advanced non-small cell lung cancer traditionally had high relapse rates after initial treatment. Now durvalumab may bring better survival rates to these patients.
We want to hear about how nursing education has been impacted by the COVID-19 pandemic.
Men receiving ADT were less likely to contract the infection that causes the coronavirus, according to a large Italian study.
Nurses need to know the potentially life-threatening adverse events of CAR T-cell therapy.
“Nurses are our frontline as far as giving these treatments and also in teaching our patients about side effects and detecting them,” Grace Cherry, NP, MSN, RN said.
Many nurses are apprehensive about continuing their schooling because of the cost. But programs do exist to reduce the financial burden.
More than 500,000 people signed a petition demanding better protection for nurses and other health care providers during the COVID-19 pandemic.
As immunotherapy continues to move into different tumor types, nurses must familiarize themselves – and their patients – with immune-related adverse events.
Cervical cancer is often diagnosed in the later stages, though incidence of the disease is declining thanks to the HPV vaccine.
Genetic testing is more important now than ever before, as biomarker-driven cancer treatments continue to receive approval across many tumor types. While these personalized treatments are improving outcomes, navigating the landscape of genetic testing can leave patients with questions for their providers.
The virtual meeting will cover new therapies, adverse event management, end-of-life care, and much more.
Strides in public health “shouldn’t carry passports,” NCCN CEO Robert W. Carlson, MD, said.
Supreme Court Justice Ruth Bader Ginsburg is undergoing chemotherapy treatment for a cancer recurrence.
Veterans with newly diagnosed lung cancer who had mental health disorders tended to have better cancer outcomes if they participated in mental health treatment.
Pap and HPV testing can decrease cervical cancer risk, but testing intervals seem to be sporadic for patients.
The FDA recently released guidelines expanding clinical trial eligibility for investigational cancer drugs for pediatric patients.
We want to hear from nurses about your comfort in having end-of-life discussions.
The drug combination can be taken orally, at home.